ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RB. Reckitt Benckiser Group Plc

6,498.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reckitt Benckiser Group Plc LSE:RB. London Ordinary Share GB00B24CGK77 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6,498.00 6,502.00 6,506.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Reckitt Benckiser Share Discussion Threads

Showing 701 to 722 of 1450 messages
Chat Pages: Latest  34  33  32  31  30  29  28  27  26  25  24  23  Older
DateSubjectAuthorDiscuss
01/11/2011
23:05
Telegraph market report...

Although Reckitt Benckiser lost its shine last week after cautioning of slower growth in the final quarter, the maker of Mr Sheen and Cillit Bang was wanted for its defensive attractions. With renewed takeover whispers also swilling round, Reckitt rose 57p to £32.55.

philanderer
27/10/2011
08:51
Questor share tip: Quarterly outlook a headache for Nurofen maker

Investors in Reckitt are likely to be reaching for the Nurofen after quarterly results from the consumer products giant prompted a significant fall in its share price.

Questor says hold.

philanderer
26/10/2011
21:29
great business, worth buying at thee levels, predator to swoop soon imo
icf absolute
26/10/2011
09:14
thats 5% off now.....
deanroberthunt
26/10/2011
09:09
phil what yesterday has done to the 2012 earnings estimates would be more
interesting if possible.

essentialinvestor
26/10/2011
08:31
The Bear Man.

Here`s a couple of downgrades for you..

26th oct ING hold tp 3750p
26th oct Liberum sell tp 2900p


also two reiterations...

26th oct Citigroup buy tp 4000p
26th oct Morgan Stanley equal weight tp 3800p

philanderer
25/10/2011
21:20
Surely the following would offset tablet generic loss somewhat:

In the U.S., the recently-launched and patent-protected Suboxone film variant continued to grow, and by the end of September had captured a 44% volume share of the total market and is now the market leader, ahead of tablets.

liarspoker
25/10/2011
16:50
Just watching here at present.
philanderer
25/10/2011
16:14
I wondered why SN. was hit today, this may expain it.
essentialinvestor
25/10/2011
16:12
from that then, looks like downgrades coming
the bear man
25/10/2011
16:03
Perhaps the following is scaring the market a bit. Am happily long here though. :O)
liarspoker
25/10/2011
15:58
Can only find one broker today and that`s UBS reiterating their 'buy' and 3800p target.
philanderer
25/10/2011
14:58
am looking for stocks where brokers are downgrading
the bear man
25/10/2011
14:21
are brokers downgrading?
the bear man
25/10/2011
13:33
That's some reaction to results - like a profit warning! Can't see they are so bad, in fact the adjusted profit at 14% growth seems to beat.
Got some on the dip.

deadly
24/10/2011
16:35
DJ EARNINGS PREVIEW: Reckitt Benckiser 3Q Op Profit Seen +13%
A rise in 3Q operating profit excluding exceptional items is expected on higher sales, driven by demand in emerging markets. Analysts say the company should report another solid quarter of earnings, with excellence in innovation setting it well among its peers, and with focus centered on the performance of its pharmaceutical division and any potential share buyback.

valedo
23/9/2011
17:22
what a share to trade in for the past few weeks !!!
broshm
08/9/2011
22:59
One tale certainly getting cold water poured on it was the idea that Reckitt Benckiser could be swallowed up by Unilever, which was being touted back in July. HSBC's Cedric Besnard claimed the likelihood of such a move was low, saying not only would the consumer goods giant be put off by the Cillit Bang maker's pharmaceutical operations, but that some of the latter's products would not be suitable for many of the former's major markets.

Reckitt shrugged this off, however, shifting up 89p to 3,295p, while Unilever closed 28p higher at 2,049p after Mr Besnard kept his "buy" recommendation, saying its potential for margin recovery was promising.

batman9
30/8/2011
09:11
The imminent release of CSD 500 will more than compensate.
deltar
29/8/2011
08:37
Agreed, there will be some sort of insurance to cover idiotic acts like this. No doubt the perperator was an animal rights organisation, an ex-employee bearing a grudge, or someone else who had a grudge against either Reckitts or Nurofen. But whatever, I suspect insurance would probably only cover tangible losses, such as the costs of the stock which has to be replaced in the recall. I doubt if it will cover intangible losses like tarnished reputation of the brand (and subsequent loss of sales) and the knock on affect to other Nurofen SKUs.
timbo003
29/8/2011
07:57
They will no doubt be covered by insurance.
deltar
25/8/2011
21:04
A down day tomorrow for Reckitt I suspect!
timbo003
Chat Pages: Latest  34  33  32  31  30  29  28  27  26  25  24  23  Older

Your Recent History

Delayed Upgrade Clock